Nearly a quarter of the new drugs approved in Canada eventually get a serious safety warning or have to be pulled from the market for safety reasons, according to a new study. And for medications that get the fast-track “priority review” by the country’s health regulator, the chance that a serious safety concern will surface is as high as a third, said Dr. Joel Lexchin. Read more here.
Study mentioned: Lexchin J. New Drugs and Safety: What Happened to New Active Substances Approved in Canada Between 1995 and 2010? Arch Intern Med. 2012 Oct 8:1-2. [Epub ahead of print] PMID: 23044937
No comments:
Post a Comment